PT952982E - Novos inibidores da hepatite b - Google Patents

Novos inibidores da hepatite b

Info

Publication number
PT952982E
PT952982E PT97946476T PT97946476T PT952982E PT 952982 E PT952982 E PT 952982E PT 97946476 T PT97946476 T PT 97946476T PT 97946476 T PT97946476 T PT 97946476T PT 952982 E PT952982 E PT 952982E
Authority
PT
Portugal
Prior art keywords
inhibitors
new hepatitis
hepatitis
new
peptides
Prior art date
Application number
PT97946476T
Other languages
English (en)
Inventor
Kenneth Murray
Michael Richard Dyson
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of PT952982E publication Critical patent/PT952982E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97946476T 1996-10-31 1997-10-31 Novos inibidores da hepatite b PT952982E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3053496P 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PT952982E true PT952982E (pt) 2004-03-31

Family

ID=21854673

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97946476T PT952982E (pt) 1996-10-31 1997-10-31 Novos inibidores da hepatite b

Country Status (11)

Country Link
US (1) US6544520B1 (pt)
EP (1) EP0952982B1 (pt)
JP (2) JP4091663B2 (pt)
AT (1) ATE255594T1 (pt)
AU (1) AU5163598A (pt)
CA (1) CA2270401A1 (pt)
DE (1) DE69726602T2 (pt)
DK (1) DK0952982T3 (pt)
ES (1) ES2207753T3 (pt)
PT (1) PT952982E (pt)
WO (1) WO1998018818A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100715954B1 (ko) 1998-12-04 2007-05-09 바이오겐 아이덱 엠에이 인코포레이티드 펩티드 리간드에 의하여 부착된 다중 면역원성 성분을보유한 ｈｂｖ 코어 항원 입자
KR100746991B1 (ko) 2004-08-06 2007-08-08 한국과학기술연구원 Ｈｂｖ 코아 단백질과 표면 단백질 간 상호작용의 측정을이용한 ｈｂｖ의 증식 억제물질의 검색방법
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법
CN101503461B (zh) * 2009-02-12 2011-09-07 北京大学人民医院 一种具有诱导肝癌细胞凋亡功能的多肽
EP4651762A1 (en) 2023-01-19 2025-11-26 SharkNinja Operating LLC Hair care appliance with powered attachment
US20240245190A1 (en) 2023-01-19 2024-07-25 Sharkninja Operating Llc Identification of hair care appliance attachments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204096A (en) 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5296572A (en) 1986-04-30 1994-03-22 James Sparrow Large pore polyamide resin and method of preparation thereof
CA1338800C (en) 1986-06-17 1996-12-17 Michael Houghton Hepatitis delta and diagnostics and vaccines
JPH02273700A (ja) 1989-04-14 1990-11-08 Olympus Optical Co Ltd ペプチド
US5547669A (en) 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
KR940000755B1 (ko) 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5556744A (en) 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5531990A (en) 1993-12-15 1996-07-02 Health Research, Inc. Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen
US5856459A (en) 1995-06-06 1999-01-05 Hybridon, Inc. Oligonucleotides specific for hepatitis B virus

Also Published As

Publication number Publication date
DK0952982T3 (da) 2004-03-29
AU5163598A (en) 1998-05-22
DE69726602D1 (en) 2004-01-15
JP2008120814A (ja) 2008-05-29
ES2207753T3 (es) 2004-06-01
WO1998018818A3 (en) 1998-07-09
DE69726602T2 (de) 2004-09-30
JP4091663B2 (ja) 2008-05-28
WO1998018818A2 (en) 1998-05-07
CA2270401A1 (en) 1998-05-07
US6544520B1 (en) 2003-04-08
JP2001503750A (ja) 2001-03-21
ATE255594T1 (de) 2003-12-15
EP0952982A2 (en) 1999-11-03
EP0952982B1 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
EP1019365A4 (en) NOVEL NEGATIVELY LOADED MOLECULE DELIVERY COMPOSITIONS
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
NO982310L (no) Protegriner
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
DE69905170T2 (de) Thiazolopyrimidinderivate
NO985981L (no) Insulinpreparater som inneholder NaCl
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
ATE398630T1 (de) Zyklische conotoxin-peptide
DE60024100D1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
ATE207076T1 (de) Ara-c derivate
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
EA200001164A1 (ru) КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
DE69309790D1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-Furyl)-3-Derivate und pharmazeutische Präparate davon, zur Behandlung von Kardiovaskulär-Erkrankungen
BG100248A (bg) Инхибитори на скваленсинтетаза